Bellevue Group Portfolio holdings
Bellevue Group is a Swiss asset manager that focuses on healthcare investing, small and mid-cap companies and other growth strategies. Martin Bisang and four other founders started it in 1993, and through its subsidiary Bank am Bellevue it first became a major name in brokerage and block trading on the Swiss market. It sold that bank to Luxembourg's KBL Group in 2019, dropping its private client business and becoming a pure asset manager. In 2016 it bought the German asset manager StarCapital to build its presence in Germany, and in 2023 it launched Bellevue Obesity Solutions, a global equity fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$5.8M |
| 2 |
Incyte
INCY
|
+$5.8M |
| 3 |
BCR
CR Bard
BCR
|
+$5.67M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$4.79M |
| 5 |
Edwards Lifesciences
EW
|
+$3.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$6.82M |
| 2 |
Illumina
ILMN
|
+$5.64M |
| 3 |
AMSG
Amsurg
AMSG
|
+$4.79M |
| 4 |
Stryker
SYK
|
+$2.92M |
| 5 |
Cigna
CI
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.51% |
| 2 | Miscellaneous | 1.07% |
| 3 | Financials | 0.42% |
Similar funds
Bellevue Group's Q4 2016 Portfolio in Review
As of Q4 2016, Bellevue Group held 126 positions worth $488M, down 12% from $553M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bellevue Group withdrew a net $17.8M in Q4 2016, closing 4 positions and reducing 35 holdings. Its most notable exit was Amsurg, an estimated $4.79M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Bellevue Group opened a new position in Danaher worth $5.76M.
- Bellevue Group's largest Q4 2016 buy was Danaher: 83,472 shares worth $5.76M.
- Bellevue Group added most to Incyte in Q4 2016, an estimated $5.8M increase.
- Bellevue Group's biggest Q4 2016 reduction was Cardinal Health, cutting an estimated $6.82M.
- Bellevue Group fully exited Amsurg in Q4 2016, selling an estimated $4.79M.
- Bellevue Group's ten largest holdings make up 33% of its $488M portfolio in Q4 2016.
- Bellevue Group opened 4 new positions and closed 4 in Q4 2016.
- Bellevue Group's portfolio value fell 12% quarter-over-quarter to $488M.
Based on Bellevue Group's 13F filing for Q4 2016, filed 10 Feb 2017.